Skip to content
Use caution Drug recall · FDA · Published November 15, 2013

Actavis Recalls BuPROPion Hydrochloride XL 150mg Due to Dissolution Failure

Actavis recalls specific lots of BuPROPion Hydrochloride Extended-Release Tablets (XL) 150mg because they failed stability testing for dissolution specifications.

🇺🇸 FDA recall #D-1043-2014DrugActavis ›
Take action

Contact the company

Recalling firmActavis Inc400 Interpace Pkwy · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

Actavis Inc is recalling BuPROPion Hydrochloride Extended-Release Tablets (XL) 150mg because the product failed stability testing for dissolution specifications at 18 months. This means the medication may not release or work as intended. The recall affects specific lots distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/46413-actavis-inc-recalls-bupropion-hydrochloride-extended-release-tablet-xl-150mg.

Source Summary by GovInfoNow · govinfonow.com/recall/46413-actavis-inc-recalls-bupropion-hydrochloride-extended-release-tablet-xl-150mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-1043-2014

Cite this page

“Actavis Recalls BuPROPion Hydrochloride XL 150mg Due to Dissolution Failure.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46413-actavis-inc-recalls-bupropion-hydrochloride-extended-release-tablet-xl-150mg. Based on FDA recall #D-1043-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1043-2014%22&limit=1).

The FDA announced on November 15, 2013, that Actavis Inc voluntarily recalled BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg due to failed dissolution specifications. The recall affects 139,944 bottles distributed nationwide and in Puerto Rico.

How to tell if you have it

  • Brand: Actavis
  • Product: BuPROPion Hydrochloride XL 150mg Tablets
  • NDC 0591-3331-30 (30 count bottle)
  • NDC 0591-3331-19 (90 count bottle)
  • NDC 0591-3331-05 (500 count bottle)
  • Lots: 524099M, 524100A, 521687A
  • Manufacturer: Watson Laboratories, Inc. Corona, CA

The hazard

The products failed stability testing for dissolution tests at the 18-month mark. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Actavis Inc has had 13 other recalls on record since March 22, 2013. Other recent recalls of similar products include Inventia Chlorthalidone Recall (September 3, 2026) and Teva Metoprolol Succinate Extended-Release Tablets Recall (January 29, 2026).

How to tell if you have this one

Check your bottle for the National Drug Code (NDC) numbers: 0591-3331-30 (30 count), 0591-3331-19 (90 count), or 0591-3331-05 (500 count). Verify the lot numbers on the label are 524099M, 524100A, or 521687A. The product is manufactured by Watson Laboratories, Inc. in Corona, CA.

  • Brand
    Actavis
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your BuPROPion Hydrochloride XL 150mg bottle matches the NDC and lot numbers listed in the recall details.

  2. Contact Your Pharmacist

    Speak with your pharmacist or healthcare provider to determine if you have the recalled product and what steps to take next.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Nov 15, 201312. FDA classified it Class III: Jan 29, 201423. Published in FDA’s Enforcement Report: Feb 5, 201434. FDA terminated the recall: Jun 16, 2015420132015
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1043-2014 (November 15, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1043-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA